603077 和邦生物
已收盘 10-23 15:00:00
资讯
新帖
简况
和邦生物：公司严格按照相关监管规则履行信息披露义务
证券之星 · 10-23 17:12
和邦生物：公司严格按照相关监管规则履行信息披露义务
和邦生物：按计划推进是基于公司实际项目进度的客观表述
证券之星 · 10-23 17:09
和邦生物：按计划推进是基于公司实际项目进度的客观表述
和邦生物：广安年产50万吨双甘膦项目拟于2027年10月建设完毕后进入投料试生产
证券之星 · 10-23 17:09
和邦生物：广安年产50万吨双甘膦项目拟于2027年10月建设完毕后进入投料试生产
和邦生物：矿业项目勘探开发有客观科学规律和周期
证券之星 · 10-23 17:09
和邦生物：矿业项目勘探开发有客观科学规律和周期
股市必读：和邦生物新发布《和邦生物关于“和邦转债”付息公告》
证券之星 · 10-22 03:53
股市必读：和邦生物新发布《和邦生物关于“和邦转债”付息公告》
和邦生物(603077.SH)：“和邦转债”将于10月28日开始付息
中金财经 · 10-20
和邦生物(603077.SH)：“和邦转债”将于10月28日开始付息
和邦生物(603077.SH)：暂未涉及磷化铟等产品的生产业务
中金财经 · 10-19
和邦生物(603077.SH)：暂未涉及磷化铟等产品的生产业务
和邦生物：公司新材料研究所主要围绕现有产业链相关的材料方向开展前期研究与技术储备
证券之星 · 10-19
和邦生物：公司新材料研究所主要围绕现有产业链相关的材料方向开展前期研究与技术储备
股市必读：和邦生物（603077）10月16日董秘有最新回复
证券之星 · 10-19
股市必读：和邦生物（603077）10月16日董秘有最新回复
和邦生物：项目计划于2027年10月31日开工
证券之星 · 10-16
和邦生物：项目计划于2027年10月31日开工
和邦生物：公司目前暂无应披露而未披露的相关信息
证券之星 · 10-16
和邦生物：公司目前暂无应披露而未披露的相关信息
和邦生物：联碱及玻璃的技改工作有序推进中
证券之星 · 10-16
和邦生物：联碱及玻璃的技改工作有序推进中
和邦生物：草甘膦为公司主要化学产品之一
证券之星 · 10-16
和邦生物：草甘膦为公司主要化学产品之一
和邦生物：拟于本年第四季度启动矿体预剥离工程
证券之星 · 10-16
和邦生物：拟于本年第四季度启动矿体预剥离工程
和邦生物：贺正刚先生的减持计划期间为2026年9月16日至2026年12月15日
证券之星 · 10-16
和邦生物：贺正刚先生的减持计划期间为2026年9月16日至2026年12月15日
和邦生物：厄尔尼诺等气候现象对除草剂需求的影响存在不确定性
格隆汇 · 10-12
和邦生物：厄尔尼诺等气候现象对除草剂需求的影响存在不确定性
股市必读：和邦生物新发布《和邦生物关于提供担保的进展公告》
证券之星 · 10-09
股市必读：和邦生物新发布《和邦生物关于提供担保的进展公告》
和邦生物：公司目前生产经营正常
证券之星 · 09-30
和邦生物：公司目前生产经营正常
和邦生物（603077）披露2026年半年度业绩说明会安排，9月24日股价下跌1.33%
证券之星 · 09-24
和邦生物（603077）披露2026年半年度业绩说明会安排，9月24日股价下跌1.33%
和邦生物：公司已形成多元化的产业布局
证券之星 · 09-18
和邦生物：公司已形成多元化的产业布局
加载更多
公司概况
公司名称：
四川和邦生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2012-07-31
主营业务：
四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品，光伏工程建设、天然气管道运输及转供、成品油销售。
发行价格：
17.50
{"stockData":{"symbol":"603077","market":"SH","secType":"STK","nameCN":"和邦生物","latestPrice":2.09,"timestamp":1792738800000,"preClose":2.07,"halted":0,"volume":120032490,"delay":0,"changeRate":0.0097,"floatShares":8832000000,"shares":8832000000,"eps":-0.0236,"marketStatus":"已收盘","change":0.02,"latestTime":"10-23 15:00:00","open":2.06,"high":2.09,"low":1.99,"amount":245000000,"amplitude":0.0483,"askPrice":2.09,"askSize":20461,"bidPrice":2.08,"bidSize":21031,"shortable":0,"etf":0,"ttmEps":-0.0236,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":2.07,"symbolType":"stock","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":2.28,"lowLimit":1.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":8831762728,"isCdr":false,"pbRate":0.98,"roa":"--","roe":"2.08%","epsLYR":-0.0672,"committee":-0.230567,"marketValue":18458000000,"turnoverRate":0.0136,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-26。","floatMarketCap":18458000000},"requestUrl":"/m/hq/s/603077","defaultTab":"news","newsList":[{"id":"2677883947","title":"和邦生物：公司严格按照相关监管规则履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2677883947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677883947?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:12","pubTimestamp":1792746731,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：对 AEV 提供贷款不需要公布吗？和邦生物回复：尊敬的投资者您好，公司与AEV的资金往来严格遵守相关法律法规及《公司章程》的规定，并已履行了必要的内部决策程序。公司严格按照相关监管规则履行信息披露义务，若相关事项达到信息披露标准，公司会严格按照规定及时公告。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0132","BK0027","BK0077","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677420739","title":"和邦生物：按计划推进是基于公司实际项目进度的客观表述","url":"https://stock-news.laohu8.com/highlight/detail?id=2677420739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677420739?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:09","pubTimestamp":1792746560,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘所谓的按计划推进是不是就是忽悠投资者的惯用词语？和邦生物回复：尊敬的投资者您好，“按计划推进”是基于公司实际项目进度的客观表述，不存在“忽悠”投资者的情形。公司始终严格遵守信息披露的真实、准确、完整原则。项目的具体进展及节点，请以公司在上海证券交易所网站及指定信息披露媒体发布的正式公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","603077","BK0077","BK0027","BK0132","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677942022","title":"和邦生物：广安年产50万吨双甘膦项目拟于2027年10月建设完毕后进入投料试生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2677942022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677942022?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:09","pubTimestamp":1792746553,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月23日在投资者关系平台上答复投资者关心的问题。广安年产50万吨双甘膦项目目前正按既定计划有序推进，项目整体工程进度符合预期，根据公司目前的工程计划，该项目拟于2027年10月建设完毕后进入投料试生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0077","BK0229","BK0196","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677947855","title":"和邦生物：矿业项目勘探开发有客观科学规律和周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2677947855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677947855?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:09","pubTimestamp":1792746551,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月23日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0077","BK0132","BK0196","BK0027","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677601096","title":"股市必读：和邦生物新发布《和邦生物关于“和邦转债”付息公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677601096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677601096?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:53","pubTimestamp":1792612388,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，和邦生物报收于2.12元，上涨0.47%，换手率0.7%，成交量62.08万手，成交额1.31亿元。公司公告汇总：和邦生物发布“和邦转债”第二年付息公告，票面利率0.50%，每张兑息0.50元，债权登记日为2026年10月27日，兑息日为2026年10月28日。付息对象为截至债权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体“和邦转债”持有人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0196","BK0077","BK0132","BK0229","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676667597","title":"和邦生物(603077.SH)：“和邦转债”将于10月28日开始付息","url":"https://stock-news.laohu8.com/highlight/detail?id=2676667597","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676667597?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:42","pubTimestamp":1792492930,"startTime":"0","endTime":"0","summary":"格隆汇10月20日丨和邦生物(603077.SH)公布，公司于2024年10月28日发行的可转换公司债券(“和邦转债”)将于2026年10月28日开始支付自2025年10月28日至2026年10月27日期间的利息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261020/32402638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0077","BK0229","BK0196","BK0132","603077","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676067155","title":"和邦生物(603077.SH)：暂未涉及磷化铟等产品的生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2676067155","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676067155?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:14","pubTimestamp":1792397641,"startTime":"0","endTime":"0","summary":"格隆汇10月19日丨和邦生物(603077.SH)在投资者互动平台表示，公司新材料研究所主要围绕现有产业链相关的材料方向开展前期研究与技术储备。 公司暂未涉及磷化铟等产品的生产业务。 公司现有2.5万吨/年黄磷产能指标，拟于乐山市犍为县布局建设黄磷生产项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261019/32401160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0196","BK0077","BK0229","603077","BK0027","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676054555","title":"和邦生物：公司新材料研究所主要围绕现有产业链相关的材料方向开展前期研究与技术储备","url":"https://stock-news.laohu8.com/highlight/detail?id=2676054555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676054555?lang=zh_cn&edition=full","pubTime":"2026-10-19 15:33","pubTimestamp":1792395187,"startTime":"0","endTime":"0","summary":"④ 现有 2.5 万吨/年黄磷指标与电子级磷/磷化铟的产业链关系是什么？公司暂未涉及磷化铟等产品的生产业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900013497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0229","159703","BK0027","603077","BK0132","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676882575","title":"股市必读：和邦生物（603077）10月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2676882575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676882575?lang=zh_cn&edition=full","pubTime":"2026-10-19 04:22","pubTimestamp":1792354930,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，和邦生物报收于2.11元，上涨0.0%，换手率0.92%，成交量81.39万手，成交额1.73亿元。③ 财务费用同比大幅上升的原因及后续利息负担展望。股份回购、现金分红、增持等事项均属于需公开披露的事项，公司目前暂无应披露而未披露的相关信息。除已披露的股东减持计划外，公司目前暂未收到其他股份变动的安排通知。如有相关事项，公司将严格依法依规及时披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900001369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0196","BK0027","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560634","title":"和邦生物：项目计划于2027年10月31日开工","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560634","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560634?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:12","pubTimestamp":1792141928,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月16日在投资者关系平台上答复投资者关心的问题。和邦生物回复：尊敬的投资者您好，根据公司公告，公司60万吨/年绿色饲料级蛋氨酸及产业配套项目已取得立项批文，环评已公示。项目计划于2027年10月31日开工，建设周期为自开工建设之日起24个月内。上述开工时间系公司初步计划，可能视市场行情、公司资金安排、项目研发进度及工艺设计情况作出调整，公司将在确保成本最优、工艺领先的前提下推进项目实施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0132","BK0196","BK0229","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560690","title":"和邦生物：公司目前暂无应披露而未披露的相关信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560690?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:09","pubTimestamp":1792141774,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月16日在投资者关系平台上答复投资者关心的问题。影响估值的因素众多，公司始终认为，长期估值最终交由市场判断。关于您提到的回购、增持等市值维护计划，公司目前暂无应披露而未披露的相关信息。未来若涉及相关事项，公司将严格按照相关法律法规及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0132","BK0077","BK0229","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675508560","title":"和邦生物：联碱及玻璃的技改工作有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2675508560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675508560?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:09","pubTimestamp":1792141762,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月16日在投资者关系平台上答复投资者关心的问题。③ 财务费用同比大幅上升的原因及后续利息负担展望。和邦生物回复：尊敬的投资者您好，公司已在2025年年度报告中披露了联碱板块及玻璃板块的技改工作相关安排，目前联碱及玻璃的技改工作有序推进中，2026年度的经营数据请在后续定期报告披露后查阅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0229","BK0027","BK0132","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560980","title":"和邦生物：草甘膦为公司主要化学产品之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560980?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:09","pubTimestamp":1792141754,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：和邦生物为什么会属于草甘膦概念板块？和邦生物回复：尊敬的投资者您好，题材概念板块的划分及成分归属通常由各行情数据服务商依据自身标准确定。草甘膦为公司主要化学产品之一，现有产能6万吨/年，在建产能35万吨/年，预计将于2027年底前投产。以上信息供您参考。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0132","BK0027","603077","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356065","title":"和邦生物：拟于本年第四季度启动矿体预剥离工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675356065?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:09","pubTimestamp":1792141752,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物10月16日在投资者关系平台上答复投资者关心的问题。项目当前进展为推进基础设施升级改造、物流协同，拟于本年第四季度启动矿体预剥离工程，并于2027年上半年实现销售。项目后续进展请以公司在上海证券交易所网站及指定信息披露媒体发布的正式公告为准。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0027","BK0077","BK0132","603077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675616560","title":"和邦生物：贺正刚先生的减持计划期间为2026年9月16日至2026年12月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2675616560","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675616560?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:03","pubTimestamp":1792141399,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：贺正刚是否已完成减持和邦生物回复：尊敬的投资者您好，根据公司已披露的公告，贺正刚先生的减持计划期间为2026年9月16日至2026年12月15日，目前上述减持计划尚在实施期内；减持进展及结果，公司将依照相关规定履行信息披露义务，请您关注公司在上海证券交易所网站及指定信息披露媒体发布的公告。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600028630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0229","BK0132","BK0027","603077","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674821944","title":"和邦生物：厄尔尼诺等气候现象对除草剂需求的影响存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2674821944","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674821944?lang=zh_cn&edition=full","pubTime":"2026-10-12 14:23","pubTimestamp":1791786199,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0077","BK0027","BK0196","BK0229","BK0132","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674400784","title":"股市必读：和邦生物新发布《和邦生物关于提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674400784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674400784?lang=zh_cn&edition=full","pubTime":"2026-10-09 03:22","pubTimestamp":1791487331,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司为全资及控股子公司提供合计8.7亿元担保，截至2026年9月30日对外担保总额61.83亿元，占最近一期经审计净资产的34.58%。上述担保在公司2026年度股东会授权额度内，无需另行审议。和邦生物关于可转债转股结果暨股份变动公告截至2026年9月30日，和邦转债累计转股金额为1,025,000元，累计转股数量512,500股，占转股前总股本的0.0058%。尚未转股的可转债金额为4,598,975,000元，占发行总量的99.9777%。股本变动显示总股本由8,831,702,728股增至8,831,762,728股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0196","BK0027","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671711032","title":"和邦生物：公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2671711032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671711032?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:00","pubTimestamp":1790755243,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：和邦生物这波短期看到1.8附近止跌，长期看到1.6附近，可对？和邦生物回复：尊敬的投资者您好，二级市场股价受行业周期、公司经营及市场情绪等多重因素影响，具体走势由市场决定，关于您提及的具体股价点位，公司不予评价。公司目前生产经营正常，相关经营信息请以后续公司定期报告及公告内容披露为准。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0229","BK0027","603077","BK0132","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196496","title":"和邦生物（603077）披露2026年半年度业绩说明会安排，9月24日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669196496?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:07","pubTimestamp":1790258868,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，和邦生物报收于2.22元，较前一交易日下跌1.33%，最新总市值为196.07亿元。该股当日开盘2.24元，最高2.26元，最低2.21元，成交额达1.86亿元，换手率为0.95%。公告显示，公司将于2026年10月12日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。投资者可于2026年9月28日至10月9日16:00前通过上证路演中心网站或公司邮箱jsy@hebang.cn提交问题。说明会后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400040801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0027","603077","BK0196","BK0132","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668941775","title":"和邦生物：公司已形成多元化的产业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2668941775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668941775?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:15","pubTimestamp":1789722946,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物09月18日在投资者关系平台上答复投资者关心的问题。公司历经多年发展，已形成多元化的产业布局，在农药、化肥等业务板块均具备深厚的产业基础和行业影响力，旗下产品在业内具有良好的口碑和品牌认知度，整体体量及综合实力在行业中占据重要地位。2026年上半年，公司实现归属于上市公司股东的净利润3.80亿元，同比增长634.30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800026648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0077","BK0132","BK0229","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792837801858,"stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0711},{"period":"3month","weight":-0.0873},{"period":"6month","weight":-0.2867},{"period":"1year","weight":-0.0142},{"period":"ytd","weight":-0.0752}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.0954},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和邦生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"236236人(较上一季度减少14.16%)","perCapita":"37385股","listingDate":"2012-07-31","address":"四川省乐山市五通桥区牛华镇沔坝村","registeredCapital":"883176万元","survey":" 四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品，光伏工程建设、天然气管道运输及转供、成品油销售。","listedPrice":17.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和邦生物,603077,和邦生物股票,和邦生物股票老虎,和邦生物股票老虎国际,和邦生物行情,和邦生物股票行情,和邦生物股价,和邦生物股市,和邦生物股票价格,和邦生物股票交易,和邦生物股票购买,和邦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}